Abstract
ObjectiveRecent studies have shown that intracranial stenting of ICAD is not superior to anti-platelet therapy alone for previously untreated patents. The question remains as to which therapy is superior in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
